Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions.

Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, Leslie C, Lieberman PM.

Cell Host Microbe. 2012 Aug 16;12(2):233-45. doi: 10.1016/j.chom.2012.06.008.

2.

Chromatin Structure of Epstein-Barr Virus Latent Episomes.

Lieberman PM.

Curr Top Microbiol Immunol. 2015;390(Pt 1):71-102. doi: 10.1007/978-3-319-22822-8_5. Review.

PMID:
26424644
3.

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Robinson AR, Kwek SS, Kenney SC.

PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.

4.

Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction.

Auburn H, Zuckerman M, Smith M.

J Med Microbiol. 2016 Nov;65(11):1243-1252. doi: 10.1099/jmm.0.000352. Epub 2016 Sep 12.

PMID:
27625030
5.

Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.

Adamson AL, Wright N, LaJeunesse DR.

Genetics. 2005 Nov;171(3):1125-35. Epub 2005 Aug 3.

6.

Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.

Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang CM, Kang W, Lung RW, Li JW, Chan TF, Xing R, Lu Y, Lo KW, Wong N, To KF, Yu C, Chan FK, Sung JJ, Yu J.

Gastroenterology. 2014 Dec;147(6):1350-62.e4. doi: 10.1053/j.gastro.2014.08.036. Epub 2014 Aug 28.

7.

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C.

J Virol. 2014 Oct;88(20):12065-76. doi: 10.1128/JVI.01431-14. Epub 2014 Aug 13.

8.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
9.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
10.

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.

Peng RJ, Han BW, Cai QQ, Zuo XY, Xia T, Chen JR, Feng LN, Lim JQ, Chen SW, Zeng MS, Guo YM, Li B, Xia XJ, Xia Y, Laurensia Y, Chia BKH, Huang HQ, Young KH, Lim ST, Ong CK, Zeng YX, Bei JX.

Leukemia. 2019 Jun;33(6):1451-1462. doi: 10.1038/s41375-018-0324-5. Epub 2018 Dec 13.

PMID:
30546078
11.

Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.

Koganti S, Clark C, Zhi J, Li X, Chen EI, Chakrabortty S, Hill ER, Bhaduri-McIntosh S.

J Virol. 2015 May;89(9):5002-11. doi: 10.1128/JVI.00121-15. Epub 2015 Feb 25.

13.

Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data.

Arvey A, Tempera I, Lieberman PM.

Viruses. 2013 Apr 2;5(4):1042-54. doi: 10.3390/v5041042. Review.

14.

Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.

Ellis-Connell AL, Iempridee T, Xu I, Mertz JE.

J Virol. 2010 Oct;84(19):10329-43. doi: 10.1128/JVI.00923-10. Epub 2010 Jul 28.

15.

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

Niller HH, Wolf H, Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Review.

PMID:
19429479
16.

Epigenetic regulation of EBV persistence and oncogenesis.

Tempera I, Lieberman PM.

Semin Cancer Biol. 2014 Jun;26:22-9. doi: 10.1016/j.semcancer.2014.01.003. Epub 2014 Jan 24. Review.

17.

Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.

Malik-Soni N, Frappier L.

J Virol. 2012 Jun;86(12):6999-7002. doi: 10.1128/JVI.00194-12. Epub 2012 Apr 11. Erratum in: J Virol. 2015 Sep;89(17):9143.

18.

[Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].

Yakovleva LS, Senyuta NB, Goncharova EV, Scherback LN, Smirnova RV, Pavlish OA, Gurtsevitch VE.

Mol Biol (Mosk). 2015 Sep-Oct;49(5):800-10. doi: 10.7868/S0026898415050213. Russian.

19.

ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.

Yu X, Wang Z, Mertz JE.

PLoS Pathog. 2007 Dec;3(12):e194.

20.

Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.

Whitehurst CB, Sanders MK, Law M, Wang FZ, Xiong J, Dittmer DP, Pagano JS.

J Virol. 2013 May;87(9):5311-5. doi: 10.1128/JVI.03505-12. Epub 2013 Feb 28.

Supplemental Content

Support Center